Luminostics’ technology and product vision were profiled in an article by Leo O’Connor for 360Dx, a diagnostics industry publication by GenomeWeb, in December 2019. Read it here (behind paywall): https://www.360dx.com/infectious-disease/luminostics-luminescent-particle-lifts-sensitivity-otc-test-prototypes.
Reach out to us for access to the full-length article!
New additions include Vice President appointments for Assay & Product Development, Quality & Regulatory Fremont, Calif – May 30, 2022 – Clip Health, a pioneer in the development of accessible and accurate diagnostics, has made two skilled additions to its leadership team. To continue innovating towards the Company’s product vision of diagnostics-enabled “full stack” healthcare,…
Clip Health joined more than 500 distributors at NDC Exhibition 2022, April 11-12, at the Gaylord Opryland Resort & Convention Center in Nashville, where the company showcased its smartphone-based COVID-19 antigen test, as well as a preview of the new Clip Core Analyzer, which will launch in June of 2021. Clip Health’s COVID-19 antigen test…